Harold D. Harvey
Columbia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Harold D. Harvey.
Cancer | 1968
Harold D. Harvey; Hugh Auchincloss
From the records of the Presbyterian Hospital, New York, 1168 patients were collected for study, all of whom had survived at least 5 years after resections for carcinoma. The majority had been followed‐up for longer than 10 years. The sites of the carcinomas were the stomach, breast, colon and rectum. The purpose of the study was to determine how many lymph nodes containing metastases had been demonstrated in the operative specimens of patients whose tumors had been apparently arrested. No matter what the site of origin of the tumor, about 72% of survivors had no metastases and about 94% had metastases in three nodes or less. Less than 3% of survivors bad metastases in more than five lymph nodes. The authors give their opinions of how the choice of operations in the future should be affected by this demonstration of the infrequent success of surgical therapy over the years when the carcinoma is not confined to a few lymph nodes close to the tumor.
Experimental Biology and Medicine | 1932
Helen Zaytseff Jern; Harold D. Harvey; Frank L. Meleney
The bacteriophage which was used for this study was found to produce a complete lysis of 2 virulent strains of B. coli which we obtained from patients with peritonitis. One one hundred billionth of a cc. of this bacteriophage caused lysis of approximately one billion bacteria of strain “T” in 10 cc. of broth. The minimal lethal dose of the “T” strain of B. coli for mice at the time of the experiments was 1-5 million organisms which killed within 5 to 12 hours after injection of an actively growing, 3-hour, 2% dextrose cooked meat medium culture. Fifty million bacteria which constituted 10-50 M.L.D.s were suspended in 0.5 cc. of broth and inoculated intraperitoneally into a series of mice. 0.5 cc. of bacteriophage was injected simultaneously into 2 of these mice, and into 2 more mice at varying intervals up to 4 1/2 hours after the bacterial inoculation. This approached closely the lethal period for control animals. In the control series plain broth injections were given at the same intervals as phage. The table shows one of these experiments. From this table one can see that 0.5 cc. of bacteriophage protected all of the mice when given up to 3 1/2 hours after bacterial inoculation. Only 50% of mice could be saved when bacteriophage was given after 4 hours. In similar experiments there was occasional recovery when phage was inoculated after 4 1/2 hours or later. Control animals receiving B. coli filtrate instead of phage were not saved. The bacteriophage itself proved to be innocuous, for 2 cc. and 4 cc. of it injected respectively into the peritoneal cavity of 2 mice did not produce any harmful effect. Both mice survived and the one inoculated with the larger dose suffered only slight discomfort for 1 or 2 hours, probably due to distention from the quantity of fluid injected.
Archives of Surgery | 1932
Frank L. Meleney; John Olpp; Harold D. Harvey; Helen Zaytseff-Jern
Annals of Surgery | 1944
Fordyce B. St. John; Paul C. Swenson; Harold D. Harvey
Annals of Surgery | 1953
Harold D. Harvey; Fordyce B. St. John; Herbert Volk
Annals of Surgery | 1948
Fordyce B. St. John; Harold D. Harvey; Jose M. Ferrer; R. W. Sengstaken
Archives of Surgery | 1931
Frank L. Meleney; Harold D. Harvey; Helen Zaytseff Jern
American Journal of Obstetrics and Gynecology | 1928
Frank L. Meleney; Zung-Dau Zau; Helen Zaytzeff; Harold D. Harvey
Annals of Surgery | 1939
Fordyce B. St. John; Harold D. Harvey; John A. Gius; Edmund N. Goodman
Annals of Surgery | 1939
Frank L. Meleney; Harold D. Harvey